Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class
March 17, 2022
Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class
aliu
Thu, 03/17/2022 – 06:26
Source link